MedTrace Logo

Ambispective Study to Assess the Effect of Pretreatment With a Levonorgestrel-Releasing Intrauterine System Versus Oral Progestin

NCT05152667 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 354

Last updated 2021-12-10

No results posted yet for this study

Summary

The study participants' relevant medical records will be collected and reviewed for the retrospective subjects and after obtaining informed consent for the prospective subjects. The study materials that will be used will include blood tests, transvaginal ultrasound and magnetic resonance imaging (MRI). The study will involve two study arms

Conditions

  • Adenomyosis
  • IVF

Interventions

DEVICE

levonorgestrel-releasing intrauterine device (LNG-IUS)

Intervention is administered proceeding the ICSI

Sponsors & Collaborators

  • National Research Centre, Egypt

    collaborator OTHER

  • Wael Elbanna Clinic

    lead OTHER

Eligibility

Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-27
Primary Completion
2022-07-31
Completion
2022-07-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05152667 on ClinicalTrials.gov